Resveratrol analogue, HS-1793, induces apoptotic cell death and cell cycle arrest through downregulation of AKT in human colon cancer cells
Authors:
- 7 November 2016
- journal article
- research article
- Published by Spandidos Publications in Oncology Reports
- Vol. 37 (1) , 281-288
Abstract
Resveratrol, a polyphenolic compound, is a naturally occurring phytochemical and is found in a variety of plants, including grapes, berries and peanuts. It has gained much attention for its potential anticancer activity against various types of human cancer. However, the usefulness of resveratrol as a chemotherapeutic agent is limited by its photosensitivity and metabolic instability. In this study the effects of a synthetic analogue of resveratrol, HS-1793, on the proliferation and apoptotic cell death were investigated using HCT116 human colon cancer cells. Although this compound has been reported to have anticancer activities in several human cancer cell lines, the therapeutic effects of HS-1793 on human colon cancer and its mechanisms of action have not been extensively studied. HS-1793 inhibited cell growth and induced apoptotic cell death in a concentration-dependent fashion. Induction of apoptosis was determined by morphological changes, cleavage of poly(ADP-ribose) polymerase, alteration of Bax/Bcl-2 expression ratio, and caspase activations. Flow cytometric analysis revealed that HS-1793 induced G2/M arrest in the cell cycle progression in HCT116 cells. Furthermore, HS-1793 showed more potent anticancer effects in several aspects than resveratrol in HCT116 cells. In addition, HS-1793 suppressed Akt and the phosphatidylinositol-3 kinase/Akt inhibitor LY294002 was found to enhance its induction of apoptosis. Thus, these findings suggest that HS-1793 have potential as a candidate chemotherapeutic agent against human colon cancer.Keywords
This publication has 29 references indexed in Scilit:
- Increasing Trend of Colorectal Cancer Incidence in Korea, 1999-2009Cancer Research and Treatment, 2012
- An Analogue of Resveratrol HS-1793 Exhibits Anticancer Activity Against MCF-7 Cells Via Inhibition of Mitochondrial Biogenesis Gene ExpressionMolecules and Cells, 2012
- The novel resveratrol analogue HS-1793 induces apoptosis via the mitochondrial pathway in murine breast cancer cellsInternational Journal of Oncology, 2012
- The Role of Mitochondria in ApoptosisAnnual Review of Genetics, 2009
- Akt2 overexpression plays a critical role in the establishment of colorectal cancer metastasisProceedings of the National Academy of Sciences, 2008
- Targeting the AKT protein kinase for cancer chemopreventionMolecular Cancer Therapeutics, 2007
- Cdc25 and Wee1: analogous opposites?Cell Division, 2007
- Resveratrol, a natural diphenol, reduces metastatic growth in an experimental cancer modelCancer Letters, 2007
- Therapeutic potential of resveratrol: the in vivo evidenceNature Reviews Drug Discovery, 2006
- Biological Effects of ResveratrolAntioxidants & Redox Signaling, 2001